for the Period Ended 30 April 2025
| Balance sheet | |
| Notes |
As at
|
Notes |
2025 |
18 months to 30 April 2024 |
|
|---|---|---|---|
|
|
£ |
£ |
|
| Fixed assets | |||
| Tangible assets: | 3 |
|
|
| Investments: | 4 |
|
|
| Total fixed assets: |
|
|
|
| Current assets | |||
| Debtors: | 5 |
|
|
| Cash at bank and in hand: |
|
|
|
| Total current assets: |
|
|
|
| Creditors: amounts falling due within one year: | 6 |
( |
( |
| Net current assets (liabilities): |
|
|
|
| Total assets less current liabilities: |
|
|
|
| Total net assets (liabilities): |
|
|
|
| Capital and reserves | |||
| Called up share capital: |
|
|
|
| Profit and loss account: |
|
|
|
| Shareholders funds: |
|
|
The notes form part of these financial statements
The directors have chosen to not file a copy of the company’s profit & loss account.
This report was approved by the board of directors on
and signed on behalf of the board by:
Name:
Status: Director
The notes form part of these financial statements
for the Period Ended 30 April 2025
for the Period Ended 30 April 2025
| 2025 | 18 months to 30 April 2024 | |
|---|---|---|
| Average number of employees during the period |
|
|
for the Period Ended 30 April 2025
| Total | |
|---|---|
| Cost | £ |
| At 01 May 2024 |
|
| At 30 April 2025 |
|
| Depreciation | |
| At 01 May 2024 |
|
| Charge for year |
|
| At 30 April 2025 |
|
| Net book value | |
| At 30 April 2025 |
|
| At 30 April 2024 |
|
for the Period Ended 30 April 2025
Fixed asset investments comprise listed equity investments and are measured at fair value through profit or loss, with changes in fair value recognised in the income statement. Fair value is determined with reference to quoted market prices at the reporting date. Dividends received are recognised in income when the right to receive payment is established. Gains and losses on disposal of investments are calculated as the difference between the sale proceeds and the carrying amount at the last valuation date. Cost or valuation At 1 May 2024: 138,089 Additions: 68,105 Disposals: (70,910) Revaluations: 9,614 At 30 April 2025: 144,898 Impairment At 1 May 2024 and 30 April 2025: – Carrying amount At 30 April 2025: 144,898 At 30 April 2024: 138,089
for the Period Ended 30 April 2025
for the Period Ended 30 April 2025